rs117747863

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2

The NM_003114.5(SPAG1):​c.1542G>A​(p.Leu514Leu) variant causes a synonymous change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00359 in 1,607,124 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0031 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0036 ( 14 hom. )

Consequence

SPAG1
NM_003114.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 7.76

Publications

1 publications found
Variant links:
Genes affected
SPAG1 (HGNC:11212): (sperm associated antigen 1) The correlation of anti-sperm antibodies with cases of unexplained infertility implicates a role for these antibodies in blocking fertilization. Improved diagnosis and treatment of immunologic infertility, as well as identification of proteins for targeted contraception, are dependent on the identification and characterization of relevant sperm antigens. The protein expressed by this gene is recognized by anti-sperm agglutinating antibodies from an infertile woman. Furthermore, immunization of female rats with the recombinant human protein reduced fertility. This protein localizes to the plasma membrane of germ cells in the testis and to the post-acrosomal plasma membrane of mature spermatozoa. Recombinant polypeptide binds GTP and exhibits GTPase activity. Thus, this protein may regulate GTP signal transduction pathways involved in spermatogenesis and fertilization. Two transcript variants of this gene encode the same protein. [provided by RefSeq, Jul 2008]
SPAG1 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 28
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia, ClinGen
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.32).
BP6
Variant 8-100220285-G-A is Benign according to our data. Variant chr8-100220285-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 416525.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00309 (471/152290) while in subpopulation NFE AF = 0.00447 (304/68022). AF 95% confidence interval is 0.00406. There are 2 homozygotes in GnomAd4. There are 233 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003114.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SPAG1
NM_003114.5
MANE Select
c.1542G>Ap.Leu514Leu
synonymous
Exon 13 of 19NP_003105.2
SPAG1
NM_001374321.1
c.1542G>Ap.Leu514Leu
synonymous
Exon 13 of 19NP_001361250.1Q07617-1
SPAG1
NM_172218.3
c.1542G>Ap.Leu514Leu
synonymous
Exon 13 of 19NP_757367.1Q07617-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SPAG1
ENST00000388798.7
TSL:1 MANE Select
c.1542G>Ap.Leu514Leu
synonymous
Exon 13 of 19ENSP00000373450.3Q07617-1
SPAG1
ENST00000251809.4
TSL:5
c.1542G>Ap.Leu514Leu
synonymous
Exon 13 of 19ENSP00000251809.3Q07617-1
SPAG1
ENST00000964470.1
c.1542G>Ap.Leu514Leu
synonymous
Exon 13 of 19ENSP00000634529.1

Frequencies

GnomAD3 genomes
AF:
0.00310
AC:
471
AN:
152172
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000724
Gnomad AMI
AF:
0.0340
Gnomad AMR
AF:
0.000851
Gnomad ASJ
AF:
0.00202
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.00763
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00447
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.00284
AC:
692
AN:
243494
AF XY:
0.00273
show subpopulations
Gnomad AFR exome
AF:
0.000558
Gnomad AMR exome
AF:
0.000527
Gnomad ASJ exome
AF:
0.00135
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00725
Gnomad NFE exome
AF:
0.00414
Gnomad OTH exome
AF:
0.00101
GnomAD4 exome
AF:
0.00365
AC:
5304
AN:
1454834
Hom.:
14
Cov.:
31
AF XY:
0.00355
AC XY:
2568
AN XY:
723540
show subpopulations
African (AFR)
AF:
0.000455
AC:
15
AN:
32946
American (AMR)
AF:
0.000565
AC:
24
AN:
42502
Ashkenazi Jewish (ASJ)
AF:
0.00116
AC:
30
AN:
25756
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39646
South Asian (SAS)
AF:
0.00129
AC:
109
AN:
84556
European-Finnish (FIN)
AF:
0.00725
AC:
387
AN:
53354
Middle Eastern (MID)
AF:
0.000871
AC:
5
AN:
5738
European-Non Finnish (NFE)
AF:
0.00407
AC:
4513
AN:
1110194
Other (OTH)
AF:
0.00367
AC:
221
AN:
60142
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
239
477
716
954
1193
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
166
332
498
664
830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00309
AC:
471
AN:
152290
Hom.:
2
Cov.:
33
AF XY:
0.00313
AC XY:
233
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.000722
AC:
30
AN:
41540
American (AMR)
AF:
0.000850
AC:
13
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00202
AC:
7
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.000621
AC:
3
AN:
4828
European-Finnish (FIN)
AF:
0.00763
AC:
81
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00447
AC:
304
AN:
68022
Other (OTH)
AF:
0.000946
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
24
48
72
96
120
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00361
Hom.:
1
Bravo
AF:
0.00260
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00507
EpiControl
AF:
0.00397

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
1
Primary ciliary dyskinesia (1)
-
-
1
Primary ciliary dyskinesia 28 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.32
CADD
Benign
8.5
DANN
Benign
0.81
PhyloP100
7.8
Mutation Taster
=35/65
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs117747863; hg19: chr8-101232513; COSMIC: COSV52561695; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.